Cell Death Regulation Laboratory, Departments of Medicine and Cell and Molecular Biology, Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL 60611, USA.
Breast Cancer Res Treat. 2010 Jan;119(1):63-70. doi: 10.1007/s10549-009-0330-4. Epub 2009 Feb 11.
Recent studies indicate that the small heat shock protein alphaB-crystallin is expressed in poor prognosis basal-like breast tumors and likely contributes to their aggressive phenotype. However, the mechanisms underlying the deregulated expression of alphaB-crystallin in basal-like tumors are poorly understood. Using a bioinformatics approach, we identified a putative DNA binding motif in the human alphaB-crystallin promoter for the proto-oncogene Ets1, a member of the ETS transcription factor family that bind to DNA at palindromic ETS-binding sites (EBS). Here we demonstrate that ectopic expression of Ets1 activates the alphaB-crystallin promoter by an EBS-dependent mechanism and increases alphaB-crystallin protein levels, while silencing Ets1 reduces alphaB-crystallin promoter activity and protein levels. Chromatin immunoprecipitation analyses showed that endogenous Ets1 binds to the alphaB-crystallin promoter in basal-like breast cancer cells in vivo. Interrogation of publically available gene expression data revealed that Ets1 is expressed in human basal-like breast tumors and is associated with poor survival. Collectively, our results point to a previously unrecognized link between the oncogenic transcription factor Ets1 and alphaB-crystallin in basal-like breast cancer.
最近的研究表明,小分子热休克蛋白 αB-晶状体蛋白在预后不良的基底样乳腺癌中表达,并可能有助于其侵袭性表型。然而,基底样肿瘤中 αB-晶状体蛋白表达失调的机制尚不清楚。我们使用生物信息学方法,在人 αB-晶状体蛋白启动子中鉴定出一个原癌基因 Ets1 的假定 DNA 结合基序,Ets1 是 ETS 转录因子家族的成员,其在回文 ETS 结合位点(EBS)处与 DNA 结合。我们在这里证明,Ets1 的异位表达通过 EBS 依赖性机制激活 αB-晶状体蛋白启动子并增加 αB-晶状体蛋白蛋白水平,而沉默 Ets1 则降低 αB-晶状体蛋白启动子活性和蛋白水平。染色质免疫沉淀分析表明,内源性 Ets1 在体内基底样乳腺癌细胞中结合到 αB-晶状体蛋白启动子上。对公开可用的基因表达数据的查询显示,Ets1 在人基底样乳腺癌肿瘤中表达,并与不良预后相关。总的来说,我们的研究结果表明,致癌转录因子 Ets1 与基底样乳腺癌中的 αB-晶状体蛋白之间存在以前未被认识到的联系。